The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
India’s economic future is increasingly tied to industries that are still evolving but promise massive…
In an unprecedented and emotionally charged development, Maharashtra witnessed a historic political moment as Sunetra…
A research team reported that they had completely eliminated the most aggressive form of pancreatic…
Rivers have always been an important part of human life, providing water, food, and transportation.…
Elena Rybakina won the Australian Open 2026 women’s singles title after defeating World No. 1…
India’s largest public sector steelmaker has achieved a milestone that goes beyond production and profits.…